Skip to main content
. 2021 Aug 11;3(5):e200301. doi: 10.1148/ryai.2021200301

Figure 1:

(A) Sample postcontrast T1-weighted images (axial section, right, anterior, and superior orientation) for the high-grade glioma (HGG), low-grade glioma (LGG), brain metastases (METS), acoustic neuroma (AN), pituitary adenoma (PA), meningioma (MEN), and healthy tissue (HLTH) classes included in the study (white arrows). (B) Class-wise distribution of data and (C) flow of images and data split for cross-validation, internal, and external testing. BraTS = Brain Tumor Image Segmentation, T1c = postcontrast T1-weighted image, TCGA = The Cancer Genome Atlas, TCGA-GBM = TCGA Glioblastoma Multiforme, WUSM = Washington University School of Medicine.

(A) Sample postcontrast T1-weighted images (axial section, right, anterior, and superior orientation) for the high-grade glioma (HGG), low-grade glioma (LGG), brain metastases (METS), acoustic neuroma (AN), pituitary adenoma (PA), meningioma (MEN), and healthy tissue (HLTH) classes included in the study (white arrows). (B) Class-wise distribution of data and (C) flow of images and data split for cross-validation, internal, and external testing. BraTS = Brain Tumor Image Segmentation, T1c = postcontrast T1-weighted image, TCGA = The Cancer Genome Atlas, TCGA-GBM = TCGA Glioblastoma Multiforme, WUSM = Washington University School of Medicine.